Specialty Pharmacy
Cardinal Report: Future Bright for Biosimilars
Biosimilars in oncology are set for major growth, with FDA streamlining approvals and new cost-saving opportunities ...
MAY 1, 2026
IRA Drug Price Negotiation Comes Home: What Infusion Pharmacies Are Learning in Year 1
The IRA's Medicare Drug Price Negotiation Program has introduced a new and unfamiliar payment structure for home ...
APRIL 25, 2026
Higher-Cost Specialty Therapies Make a Move Toward Front-Line Status
Specialty therapies like IL-23 and JAK inhibitors are moving into earlier treatment lines, reshaping care and ...
APRIL 24, 2026
Pharmacists and Nurses Partner to Smooth Pediatric Ig Therapy
Infusion pharmacists and nurses both play a part in improving the experience of children who receive IV or ...
APRIL 23, 2026
Radiopharmaceuticals Shine in Detecting, Treating Cancer
Radiopharmaceuticals are reshaping cancer care—experts discuss growth, costs, access, and managed care ...
APRIL 22, 2026
The Promise and Pain of GLP-1s on Tap at AMCP Nexus
Glucagon-like peptide-1 drugs were a hot topic at AMCP Nexus 2025, with three presentations spotlighting the ...
APRIL 21, 2026
High-Dose Opioids in Cancer Yield Poor Clinical and Financial Outcomes
High-dose opioid therapy in disease-free cancer survivors is significantly cost-inefficient and associated with ...
APRIL 20, 2026
Is AI the Future of Safe Hazardous Drug Handling?
USP <800> compliance challenges and outdated NIOSH HD lists drive pharmacists to explore AI solutions for ...
APRIL 19, 2026
For Older Adults With HIV, Extending “Healthspan” Is the New Frontier
HIV and aging: People with HIV are living longer but face higher risks of frailty, cognitive decline, and ...
APRIL 16, 2026
First Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Tardive dyskinesia in long-term care: new expert consensus offers structured guidance for screening, diagnosis, and ...
APRIL 13, 2026
What It Takes to Deliver Anti-Amyloid Alzheimer’s Rx in Real-World Practice
Alzheimer’s anti-amyloid therapy implementation challenges—staffing, imaging, pharmacist roles, and ...
APRIL 10, 2026
‘Liver Detox’ Bestsellers Pull in $39M a Year, Despite Thin Evidence
The 20 highest-ranked purported “liver-cleansing” products sold on Amazon generated almost $40 million ...
APRIL 2, 2026
